Foundation Medicine to Develop Sequencing-Based Comprehensive Cancer Test for Novartis

"This test will look comprehensively at several hundred genes by deep sequencing," Foundation Medicine's CEO said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.